Caterina Ercolani

Statistics

Publications

Citations

241

H-Index

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

IRBM Science Park

Caterina Ercolani is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in viral hepatitis, medicinal chemistry, and antiviral pharmacology.

Publications per year

2006–2011

Publications

Discovery of (7R)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase

Frank Narjes, Benedetta Crescenzi, Marco Ferrara et al. · Journal of Medicinal Chemistry · 2010 · 66 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase

Ian Stansfield, Caterina Ercolani, Angela Mackay et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 52 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase

Jesus M. Ontoria, José Ignacio Martı́n Hernando, Savina Malancona et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 45 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Development of carboxylic acid replacements in indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase

Ian Stansfield, Marco Pompei, Immacolata Conte et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 34 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture

Immacolata Conte, Claudio Giuliano, Caterina Ercolani et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 34 citations

Medicine, Medicinal Chemistry, Pharmacology +14

1–5 of 6